Mirae Asset Global ETFs Holdings
INDV icon

Mirae Asset Global ETFs Holdings’s Indivior Pharmaceuticals INDV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Sell
55,238
-1,593
-3% -$57.8K ﹤0.01% 1176
2026
Q1 		$1.73M Buy
56,831
+465
+0.8% +$15.4K ﹤0.01% 1245
2025
Q4 		$2.02M Buy
56,366
+5
+0% +$153 ﹤0.01% 1140
2025
Q3 		$1.36M Sell
56,361
-10,125
-15% -$212K ﹤0.01% 1317
2025
Q2 		$980K Buy
+66,486
New +$774K ﹤0.01% 1450

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's INDV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Indivior Pharmaceuticals (INDV) stake by 2.8% in Q2 2026, selling an estimated $57.8K and leaving 55,238 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Mirae Asset Global ETFs Holdings first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 55,238 shares of Indivior Pharmaceuticals worth $2.27M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,593 Indivior Pharmaceuticals shares in Q2 2026, an estimated $57.8K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1176 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.